Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia.
Krajinovic M, Elbared J, Drouin S, Bertout L, Rezgui A, Ansari M, Raboisson MJ, Lipshultz SE, Silverman LB, Sallan SE, Neuberg DS, Kutok JL, Laverdière C, Sinnett D, Andelfinger G. Krajinovic M, et al. Among authors: bertout l. Pharmacogenomics J. 2017 Jan;17(1):107. doi: 10.1038/tpj.2016.86. Epub 2016 Dec 13. Pharmacogenomics J. 2017. PMID: 27958382 No abstract available.
Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia.
Krajinovic M, Elbared J, Drouin S, Bertout L, Rezgui A, Ansari M, Raboisson MJ, Lipshultz SE, Silverman LB, Sallan SE, Neuberg DS, Kutok JL, Laverdière C, Sinnett D, Andelfinger G. Krajinovic M, et al. Among authors: bertout l. Pharmacogenomics J. 2016 Nov;16(6):530-535. doi: 10.1038/tpj.2015.63. Epub 2015 Sep 8. Pharmacogenomics J. 2016. PMID: 26345518 Clinical Trial.
Genetic factors contributing to late adverse musculoskeletal effects in childhood acute lymphoblastic leukemia survivors.
Shalmiev A, Nadeau G, Aaron M, Ouimet-Grennan E, Drouin S, Bertout L, Beaulieu P, St-Onge P, Veilleux LN, Rauch F, Rezgui A, Petrykey K, Laverdière C, Sinnett D, Alos N, Krajinovic M. Shalmiev A, et al. Among authors: bertout l. Pharmacogenomics J. 2022 Feb;22(1):19-24. doi: 10.1038/s41397-021-00252-6. Epub 2021 Aug 26. Pharmacogenomics J. 2022. PMID: 34446917
Genetic factors in treatment-related cardiovascular complications in survivors of childhood acute lymphoblastic leukemia.
Petrykey K, Rezgui AM, Guern ML, Beaulieu P, St-Onge P, Drouin S, Bertout L, Wang F, Baedke JL, Yasui Y, Hudson MM, Raboisson MJ, Laverdière C, Sinnett D, Andelfinger GU, Krajinovic M. Petrykey K, et al. Among authors: bertout l. Pharmacogenomics. 2021 Sep;22(14):885-901. doi: 10.2217/pgs-2021-0067. Epub 2021 Sep 10. Pharmacogenomics. 2021. PMID: 34505544 Free PMC article.
Identification of a single-nucleotide polymorphism within CDH2 gene associated with bone morbidity in childhood acute lymphoblastic leukemia survivors.
Aaron M, Nadeau G, Ouimet-Grennan E, Drouin S, Bertout L, Beaulieu P, St-Onge P, Shalmiev A, Veilleux LN, Rauch F, Petrykey K, Laverdière C, Sinnett D, Alos N, Krajinovic M. Aaron M, et al. Among authors: bertout l. Pharmacogenomics. 2019 Apr;20(6):409-420. doi: 10.2217/pgs-2018-0169. Epub 2019 Apr 15. Pharmacogenomics. 2019. PMID: 30983502
Identification of genetic variants associated with skeletal muscle function deficit in childhood acute lymphoblastic leukemia survivors.
Nadeau G, Ouimet-Grennan E, Aaron M, Drouin S, Bertout L, Shalmiev A, Beaulieu P, St-Onge P, Veilleux LN, Rauch F, Petrykey K, Laverdière C, Sinnett D, Alos N, Krajinovic M. Nadeau G, et al. Among authors: bertout l. Pharmgenomics Pers Med. 2019 Apr 11;12:33-45. doi: 10.2147/PGPM.S192924. eCollection 2019. Pharmgenomics Pers Med. 2019. PMID: 31114288 Free PMC article.
Physical Activity and Sedentary Behaviors in Childhood Acute Lymphoblastic Leukemia Survivors.
Lemay V, Caru M, Samoilenko M, Drouin S, Mathieu ME, Bertout L, Lefebvre G, Raboisson MJ, Krajinovic M, Laverdière C, Andelfinger G, Sinnett D, Curnier D. Lemay V, et al. Among authors: bertout l. J Pediatr Hematol Oncol. 2020 Jan;42(1):53-60. doi: 10.1097/MPH.0000000000001594. J Pediatr Hematol Oncol. 2020. PMID: 31568179 Clinical Trial.
Doxorubicin treatments induce significant changes on the cardiac autonomic nervous system in childhood acute lymphoblastic leukemia long-term survivors.
Caru M, Corbin D, Périé D, Lemay V, Delfrate J, Drouin S, Bertout L, Krajinovic M, Laverdière C, Andelfinger G, Sinnett D, Curnier D. Caru M, et al. Among authors: bertout l. Clin Res Cardiol. 2019 Sep;108(9):1000-1008. doi: 10.1007/s00392-019-01427-9. Epub 2019 Feb 18. Clin Res Cardiol. 2019. PMID: 30778669
29 results